International Stem Cell joins StockProfile.com

NewsGuard 100/100 Score

International Stem Cell Corporation (OTCBB: ISCO), www.internationalstemcell.com, announced today that it has expanded its market awareness program by joining www.StockProfile.com, a customized web-based platform showcasing emerging growth stocks.

“This is another important step ISCO is taking to ensure that its shareholders and the investment community have continued access to information about our latest announcements, products and services. We're pleased to add StockProfile.com to our market awareness program and we will continue to explore additional market outreach strategies.”

StockProfile.com provides the investing public with a free unique information portal for investors who like to conduct their own research and make their own investment decisions. The platform allows users to review and investigate dynamic publicly traded companies in a user-friendly environment.

International Stem Cell Corporation is pleased to provide corporate information to StockProfile.com’s independent investors seeking information about new growth companies. The profile is listed at www.StockProfile.com and can be viewed by searching under the stock symbol ISCO.

Brian Lundstrom, President of ISCO said, "This is another important step ISCO is taking to ensure that its shareholders and the investment community have continued access to information about our latest announcements, products and services. We're pleased to add StockProfile.com to our market awareness program and we will continue to explore additional market outreach strategies.”

SOURCE International Stem Cell Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Japanese researchers test cardiac spheroids for heart regeneration in monkeys